Our study has validated the significant upregulation of the core clock gene BMAL1 in PTC samples, previously shown by us in a smaller subset of samples as strongly upregulated in PTC and FTC [3]. The gene discussed is CLOCK; the disease is thyroid cancer, nonmedullary, 2.